Seer (SEER) Long-Term Investments (2021 - 2026)
Seer (SEER) posted quarterly Long-Term Investments of $52.8 million for Q1 2026, up 15.84% year-over-year from $45.6 million in Q1 2025, and down 3.45% quarter-over-quarter from $54.7 million in Q4 2025.
Seer (SEER) Long-Term Investments (2021 - 2026) Analysis & Trends
Seer's Long-Term Investments history runs 6 years deep, the most recent figure standing at $52.8 million for Q1 2026.
- In Q1 2026, Long-Term Investments rose 15.84% year-over-year to $52.8 million; the TTM figure through Mar 2026 stood at $52.8 million (up 15.84% YoY), while the FY2025 annual figure was $54.7 million, down 13.34% from the prior year.
- Long-Term Investments for Q1 2026 stood at $52.8 million, down from $54.7 million in the prior quarter.
- The five-year high for Long-Term Investments was $75.8 million in Q2 2023, with the low at $4.9 million in Q3 2022.
- The 5-year median for Long-Term Investments is $52.8 million (2026), against an average of $45.9 million.
- The sharpest annual moves came in 2022 and 2023: Long-Term Investments plunged 94.47% in 2022, then surged 1442.22% in 2023.
- Seer's Long-Term Investments stood at $5.2 million in 2022, then jumped by 1002.54% to $56.9 million in 2023, then increased by 10.98% to $63.1 million in 2024, then slipped by 13.34% to $54.7 million in 2025, then slipped by 3.45% to $52.8 million in 2026.
- Business Quant data shows SEER's Long-Term Investments at $52.8 million in Q1 2026, $54.7 million in Q4 2025, and $52.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 372.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.17 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 56.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.63 Mn |
| Mar 31, 2026 | 52.80 Mn |
| Dec 31, 2025 | 54.69 Mn |
| Sep 30, 2025 | 51.95 Mn |
| Jun 30, 2025 | 53.40 Mn |
| Mar 31, 2025 | 45.58 Mn |
| Dec 31, 2024 | 63.10 Mn |
| Sep 30, 2024 | 64.90 Mn |
| Jun 30, 2024 | 61.20 Mn |
| Mar 31, 2024 | 50.64 Mn |
| Dec 31, 2023 | 56.86 Mn |
| Sep 30, 2023 | 49.60 Mn |
| Jun 30, 2023 | 75.80 Mn |
| Mar 31, 2023 | 58.42 Mn |
| Dec 31, 2022 | 5.16 Mn |
| Sep 30, 2022 | 4.87 Mn |
| Jun 30, 2022 | 4.92 Mn |
| Mar 31, 2022 | 26.55 Mn |
| Dec 31, 2021 | 93.19 Mn |